Penny Wise and Pound Foolish: Will Shortsighted Cost Reduction Measures Compromise Patient Access to Promising Self-Monitoring of Blood Glucose Technology?

por Parkin, Christopher G.
Publicado em 2013

Medicare Competitive Bidding Program: Designed to Fail

por Parkin, Christopher G.
Publicado no J Diabetes Sci Technol (2017)

If SMBG Accuracy Is Critical to Patient Safety, Why Are Inaccurate Meters Still on the Market?

por Parkin, Christopher G.
Publicado no J Diabetes Sci Technol (2017)

Randomized Studies Are Needed to Assess the True Role of Self-Monitoring of Blood Glucose in Noninsulin-Treated Type 2 Diabetes

por Parkin, Christopher G., Price, David
Publicado em 2007

Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice

por Heinemann, Lutz, Parkin, Christopher G.
Publicado no J Diabetes Res (2018)

Value of Self-Monitoring Blood Glucose Pattern Analysis in Improving Diabetes Outcomes

por Parkin, Christopher G., Davidson, Jaime A.
Publicado em 2009

Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: Does proving this relationship really matter? Yes

por Davidson, Jaime A., Parkin, Christopher G.
Publicado em 2009

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

por Unger, Jeffrey R., Parkin, Christopher G.
Publicado em 2011

Unknown Safety and Efficacy of Smartphone Bolus Calculator Apps Puts Patients at Risk for Severe Adverse Outcomes

por Hirsch, Irl B., Parkin, Christopher G.
Publicado no J Diabetes Sci Technol (2016)

7(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG), May 8–10, 2014, Helsinki, Finland

por Parkin, Christopher G., Mlinac, Anita, Hinzmann, Rolf
Publicado em 2014

Comparison of Intensive Insulin Therapy Using a Bolus Calculator in Type 1 vs. Type 2

por Wagner, Robin S., Koehler, Walter, Parkin, Christopher G.
Publicado no J Diabetes Sci Technol (2014)

8(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG): April 16–18, 2015, Republic of Malta

por Parkin, Christopher G., Homberg, Anita, Hinzmann, Rolf
Publicado no Diabetes Technol Ther (2015)

Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization

por Parkin, Christopher G., Graham, Claudia, Smolskis, John
Publicado no J Diabetes Sci Technol (2017)

10th Annual Symposium on Self-Monitoring of Blood Glucose, April 27–29, 2017, Warsaw, Poland

por Parkin, Christopher G., Homberg, Anita, Hinzmann, Rolf
Publicado no Diabetes Technol Ther (2018)

12th Roche Diabetes Care Network Meeting: April 11–13, 2019, Copenhagen, Denmark

por Parkin, Christopher G., Zepezauer, Christine, Hinzmann, Rolf
Publicado no Diabetes Technol Ther (2020)

Safe and Efficacious Use of Automated Bolus Advisors in Individuals Treated With Multiple Daily Insulin Injection (MDI) Therapy: Lessons Learned From the Automated Bolus Advisor Co...

por Parkin, Christopher G., Barnard, Katharine, Hinnen, Deborah A.
Publicado no J Diabetes Sci Technol (2015)

Efficacy of the Omnipod Insulin Management System on Glycemic Control in Patients With Type 1 Diabetes Previously Treated With Multiple Daily Injections or Continuous Subcutaneous...

por Layne, Jennifer E., Parkin, Christopher G., Zisser, Howard
Publicado no J Diabetes Sci Technol (2016)

Efficacy of a Tubeless Patch Pump in Patients With Type 2 Diabetes Previously Treated With Multiple Daily Injections

por Layne, Jennifer E., Parkin, Christopher G., Zisser, Howard
Publicado no J Diabetes Sci Technol (2016)

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program

por Billings, Liana K., Parkin, Christopher G., Price, David
Publicado no Diabetes Technol Ther (2018)

Optimizing mHealth Technologies in Real-World Clinical Practices

por Mora, Pablo, Biggs, William C., Parkin, Christopher G.
Publicado no Clin Diabetes (2019)